Madison drug company Cellectar to merge with Boston’s Novelos

With the merger, Novelos will shift its official headquarters from Newton, Mass., to Madison.There, a team led by University of Wisconsin-Madison radiology professor Jamey Weichert will continue research into three cancer-targeted compounds dubbed Cold, Hot and Light. Administrative offices will be in Massachusetts.